
CCSI Stock Forecast & Price Target
CCSI Analyst Ratings
Bulls say
Consensus Cloud Solns is well positioned because its shift from legacy eFaxing toward a healthcare interoperability and secure data-exchange platform is unlocking faster Corporate growth, stronger retention, and stickier enterprise use cases. Its 2Q:26 results showed the thesis improving, with revenue up 4% y/y to $91.4M, Corporate revenue up 9% y/y, adjusted EBITDA of $48.3M, and a 52.9% margin supported by ~80% gross margin and 103.1% net revenue retention. The balance sheet also strengthens the outlook, as debt has fallen from about $794M in 2022 to $548M in 2Q:26, leaving leverage at 2.8x and free cash flow near $120M annually for reinvestment and further de-risking.
Bears say
Consensus Cloud Solns is facing a fundamentally challenged setup because its legacy SoHo business, while still generating cash, declined to $30.9 million in 2Q 2026, down 4.7% year over year, and management expects another 5% to 7% decline in each of Q3 and Q4 2026. The company is intentionally treating SoHo as a cash-harvest segment rather than a growth engine, which underscores limited organic expansion and dependence on corporate growth to offset the drag. Its outlook is further pressured by a heavy debt load, intense competition from large and smaller technology rivals, and the risk that customers could reduce spending or build similar capabilities in-house if the value proposition weakens.
This aggregate rating is based on analysts' research of Consensus Cloud Solutions and is not a guaranteed prediction by Public.com or investment advice.
CCSI Analyst Forecast & Price Prediction
Start investing in CCSI
Order type
Buy in
Order amount
Est. shares
0 shares